Eam Investors, LLC Iveric Bio, Inc. Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	BUY	$18.67 - $24.56 $1.68 Million - $2.21 Million	90,079 New	90,079 $2.19 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $886,515 - $1.23 Million	-51,422 Reduced 33.9%	100,271 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $1.43 Million - $2.82 Million	151,693 New	151,693 $2.72 Million
Q2 2022 Aug 12, 2022	SELL	$9.12 - $18.9 $1.42 Million - $2.94 Million	-155,778 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $415,955 - $576,175	-34,235 Reduced 18.02%	155,778 $2.62 Million

Q4 2021 Feb 11, 2022	SELL	$13.83 - $18.78 $623,373 - $846,489	-45,074 Reduced 19.17%	190,013 $3.18 Million
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $1.66 Million - $4.11 Million	235,087 New	235,087 $3.82 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.